|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 491/052 | |
| A61K 31/4188 | |||
| A61P 31/12 |
| (11) | Number of the document | 2850085 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13726936.1 |
| Date of filing the European patent application | 2013-05-15 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/041201 |
| Date | 2013-05-15 |
| (87) | Number | WO 2013/173488 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261647966 P | 2012-05-16 | US | |
| 201313831116 | 2013-03-14 | US |
| (72) |
LINK, John O., US
COTTELL, Jeromy J., US
TREJO MARTIN,Teresa Alejandra, US
BACON, Elizabeth M., US
|
| (73) |
Gilead Pharmasset LLC,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5A |
| ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5A |